{"schema_version":"secwatch.filing_event.v1","accession":"0001615219-24-000062","form_type":"8-K","ticker":"DCOY","cik":"0001615219","company_name":"Decoy Therapeutics Inc.","filed_at":"2024-07-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.781877+00:00","generated_at":"2026-05-31T18:06:10.616220+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Salarius Pharmaceuticals files prospectus supplement for $810,973 at-the-market offering","bullets":["At-the-market offering of up to $810,973 of common stock via Ladenburg Thalmann & Co. Inc.","Prospectus supplement filed July 22, 2024 under existing S-3 registration statement (File No. 333-266589).","Legal opinion of Hogan Lovells US LLP on share validity filed as Exhibit 5.1."],"urls":{"canonical":"https://secwatch.observer/filing/0001615219-24-000062","json":"https://secwatch.observer/filing/0001615219-24-000062.json","markdown":"https://secwatch.observer/filing/0001615219-24-000062.md","text":"https://secwatch.observer/filing/0001615219-24-000062.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1615219/000161521924000062/0001615219-24-000062-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1615219/000161521924000062/flks-20240722.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T18:06:10.616220+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}